Angeles Wealth Management »

Cue Biopharma shares owned by Angeles Wealth Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Angeles Wealth Management from 13F filings

Historical chart of Angeles Wealth Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Angeles Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Angeles Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $86k 120k 0.72
2025-06-30 $82k 120k 0.68

More positions owned by Angeles Wealth Management

Vanguard World Mega Grwth Ind (MGK)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr National Mun Etf (MUB)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ares Management Corporation Cl A Com Stk (ARES)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Msci Jpn Etf New (EWJ)

View all positions for Angeles Wealth Management

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Advisory Research
Renaissance Technologies
UBS Group
Stifel Financial
State Street Corporation
Susquehanna International
Angeles Wealth Management
Northern Trust

View all funds holding Cue Biopharma